l-carnitine fatty liver l carnitine therapy in non alcoholic steatohepatitis Nonalcoholic Disease and Gut-liver Axis: Role of Intestinal Microbiota and Therapeutic Mechanisms Carnitine metabolic disorders and novel – L-Carnitine for Fatty Liver Disease

Recht auf Datenbertragbarkeit Du hast das Recht, Daten, die wir auf Grundlage deiner Einwilligung oder in Erfllung eines Vertrags automatisiert verarbeiten, an dich oder an einen Dritten in einem gngigen, maschinenlesbaren Format aushndigen zu lassen

We thank Mark Cleasby, PhD, from Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript

MonteiroASantosSGonalvesP

[PubMed] Baghban F, Hosseinzadeh M, Mozaffari-Khosravi H, Dehghan A, Fallahzadeh H (2021) The effect of L-Carnitine supplementation on clinical symptoms, C-reactive protein and malondialdehyde in obese women with knee osteoarthritis: A double blind randomized controlled trial

Acetyl-l-carnitine versus placebo for migraine prophylaxis: a randomized, triple-blind, crossover study

While untreated metabolic crises can cause brain injury and developmental delays, daily L-carnitine treatment protects brain development